Importantly, KEGG enrichment analysis suggested that all the enriched signaling pathways of the AKR1B10 high-expression group were associated with cancer, including the cell cycle, P53 signaling pathway, and pathways in cancer (Figure 6A and Supplementary Table S5). Here, AKR1B10 is linked to cancer.